Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Axogen, Inc. | d585305dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 15, 2013
AXOGEN, INC.
(Exact name of registrant as specified in its charter)
| Minnesota | 1-36046 | 41-1301878 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number |
(IRS Employer Identification No.) |
| 13859 Progress Boulevard, Suite 100, Alachua, Florida |
32615 | |
| (Address of Principal Executive Offices) | (Zip Cope) |
Registrant’s telephone number, including area code
(386) 462-6800
(Former name or former address if changed since last report,)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Information
On August 15, 2013, AxoGen, Inc. (the “Company”) issued a press release announcing the completion of the underwritten offering of 6,000,000 shares of common stock at a price to the public of $3.00 per share (before underwriting discount) and the filing of its quarterly report on Form 10-Q for the second quarter of 2013.
In connection with the offering, the Company received gross proceeds of approximately $18 million, excluding the underwriters’ over-allotment option and deductions for underwriting discounts and commissions and estimated expenses. JMP Securities LLC acted as the sole book-running manager in the offering and Ladenburg Thalmann & Co. Inc., acted as co-manager.
A copy of the press release is filed herewith as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 | AxoGen, Inc. press release, dated August 15, 2013. | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AXOGEN, INC. | ||||||
| Date: August 15, 2013 |
By: | /s/ Gregory G. Freitag | ||||
| Gregory G. Freitag | ||||||
| Chief Financial Officer | ||||||
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 | AxoGen, Inc. press release, dated August 15, 2013. | |